ID | 119490 |
Author |
Yamakage, Hajime
NHO Kyoto Medical Center
Jo, Takaaki
Fushimi Momoyama General Hospital
Tanaka, Masashi
NHO Kyoto Medical Center|Health Science University
Kato, Sayaka
NHO Kyoto Medical Center|Kyoto Prefectural University of Medicine
Hasegawa, Koji
NHO Kyoto Medical Center
Masuda, Izuru
NHO Kyoto Medical Center
Matsuhisa, Munehide
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Kotani, Kazuhiko
Jichi Medical University
Noda, Mitsuhiko
International University of Health and Welfare|Saitama Medical University
Satoh-Asahara, Noriko
NHO Kyoto Medical Center|Nagoya University
|
Keywords | obesity
weight loss
metabolic syndrome
cohort study
5-year follow-up
|
Content Type |
Journal Article
|
Description | Objective: This study aimed to identify the amount of weight loss needed in patients with obesity to improve metabolic syndrome (MetS), a risk factor for cardiovascular disease (CVD), over a long period of time.
Methods: A total of 576 patients with obesity were enrolled in this study. Effects of continuous physician-supervised weight loss on the cumulative MetS components excluding abdominal circumference (defined as obesity-related CVD risk score) were investigated during a 5-year follow-up period. The extent of weight loss required to reduce the obesity-related CVD risk components was assessed using receiver operating characteristic (ROC) curve analyses. Results: Of the 576 participants, 266 completed 5-year follow-up, with 39.1% and 24.1% of them achieving ≥5.0% and ≥7.5% weight loss at the 5-year follow-up, respectively. The area under the ROC curve for reducing the obesity-related CVD risk components was 0.719 [0.662–0.777] at 1 year and 0.694 [0.613–0.775] at 5 years. The optimal cut-off value for weight loss was 5.0% (0.66 sensitivity and 0.69 specificity) and the value with 0.80 specificity was 7.5% (0.45 sensitivity) at 5 years. Greater reductions in weight were associated with greater improvements in the obesity-related CVD risk score at all follow-up periods (P-trend <0.001). Obesity-related CVD risk score was significantly improved by 5.0–7.5% and ≥7.5% weight loss at 1 year (P = 0.029 and P < 0.001, respectively) and ≥7.5% weight loss at 5 years (P = 0.034). Conclusions: A weight loss of ≥5.0% at 1 year and ≥7.5% at 5 years could reduce the number of obesity-related CVD risk components in patients with obesity. |
Journal Title |
Frontiers in Endocrinology
|
ISSN | 16642392
|
Publisher | Frontiers
|
Volume | 15
|
Start Page | 1343153
|
Published Date | 2024-03-27
|
Rights | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
|
EDB ID | |
DOI (Published Version) | |
URL ( Publisher's Version ) | |
FullText File | |
language |
eng
|
TextVersion |
Publisher
|
departments |
Institute of Advanced Medical Sciences
|